SOLARA ACTIVE PHARMA SCIENCES
Back to Balance Sheet
|
SOLARA ACTIVE PHARMA SCIENCES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹191 Cr | ₹172 Cr | ₹217 Cr | ₹299 Cr | ₹206 Cr |
What is the latest Total Non-Current Liabilities ratio of SOLARA ACTIVE PHARMA SCIENCES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹191 Cr |
| Mar2024 | ₹172 Cr |
| Mar2023 | ₹217 Cr |
| Mar2022 | ₹299 Cr |
| Mar2021 | ₹206 Cr |
How is Total Non-Current Liabilities of SOLARA ACTIVE PHARMA SCIENCES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹191 Cr | 11.25 | |
| Mar2024 | ₹172 Cr | -21.00 | |
| Mar2023 | ₹217 Cr | -27.43 | |
| Mar2022 | ₹299 Cr | 44.93 | |
| Mar2021 | ₹206 Cr | - | |
Compare Total Non-Current Liabilities of peers of SOLARA ACTIVE PHARMA SCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SOLARA ACTIVE PHARMA SCIENCES | ₹2,713.7 Cr | -6.6% | -2.3% | 14.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹440,794.0 Cr | 0.9% | -3.1% | 7.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹178,956.0 Cr | 2% | -2.1% | -0.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,820.0 Cr | -2.9% | -0.3% | 36.4% | Stock Analytics | |
| CIPLA | ₹109,370.0 Cr | -2.4% | -3.8% | -10.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,133.0 Cr | -0.5% | -5% | -6.9% | Stock Analytics | |
SOLARA ACTIVE PHARMA SCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SOLARA ACTIVE PHARMA SCIENCES | -6.6% |
-2.3% |
14.5% |
| SENSEX | 4.9% |
2.8% |
-6.2% |
You may also like the below Video Courses